Hippocampus News and Research

RSS

The hippocampus is a part of the forebrain, located in the medial temporal lobe. It belongs to the limbic system and plays major roles in short term memory and spatial navigation. Humans and other mammals have two hippocampi, one in each side of the brain.

C3a peptide regulates the generation of new nerve cells in the brain: Study

The generation of new nerve cells in the brain is regulated by a peptide known as C3a, which directly affects the stem cells' maturation into nerve cells and is also important for the migration of new nerve cells through the brain tissue, reveals new research from the Sahlgrenska Academy published in the journal Stem Cells.

23 Nov 2009

Foods rich in antioxidant substances could delay the onset of Alzheimer's disease

Universitat Autònoma de Barcelona (UAB) researchers have confirmed that a diet rich in polyphenols and polyunsaturated fatty acids, patented as an LMN diet, helps boost the production of the brain's stem cells -neurogenesis- and strengthens their differentiation in different types of neuron cells.

23 Nov 2009

Brain uses a mechanism to filter out distracting thoughts to focus on single information

The human brain is bombarded with all kinds of information, from the memory of last night's delicious dinner to the instructions from your boss at your morning meeting. But how do you "tune in" to just one thought or idea and ignore all the rest of what is going on around you, until it comes time to think of something else?

19 Nov 2009

Possible new approach to slow the progression of cognitive decline in Down's syndrome

A study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the University of California, San Diego School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down's syndrome.

19 Nov 2009

New neuroimaging techniques yield new insights on Alzheimer's disease

Brain imaging can offer a window into risk for diseases such as Alzheimer's disease (AD). A study conducted at the University of Kansas School of Medicine demonstrated that genetic risk is expressed in the brains of even those who are healthy, but carry some risk for AD. The results of this study are published in the November 2009 issue of the Journal of Alzheimer's Disease.

18 Nov 2009

Scientists develop new technique to measure brain volume loss for monitoring of Alzheimer's disease

In a study that promises to improve diagnosis and monitoring of Alzheimer's disease, scientists at the University of California, San Diego have developed a fast and accurate method for quantifying subtle, sub-regional brain volume loss using magnetic resonance imaging (MRI). The study will be published the week of November 16 in the Proceedings of the National Academy of Sciences (PNAS).

16 Nov 2009

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Mithridion, Inc., a biopharmaceutical company focusing on developing drugs for serious Central Nervous System (CNS) disorders, announced today progress with its pipeline of potential oral small-molecule drugs for Alzheimer's disease (AD) and schizophrenia.

13 Nov 2009

Weizmann Institute scientists reveal how some aromas are bound up in our memories

From Proust's Madeleines to the overbearing food critic in the movie Ratatouille who's transported back to his childhood at the aroma of stew, artists have long been aware that some odors can spontaneously evoke strong memories

10 Nov 2009

Advanced equipment targets radiation to specific areas in the brain

Radiation oncologists at Rush University Medical Center are intent on finding ways to avoid damage to the critically important hippocampus and limbic circuit of the brain when cranial radiation is required to treat existing or potential metastatic cancers.

4 Nov 2009

Study: Estrogen replacement may help protect brain damage

Eighteen years ago this month the National Institutes of Health (NIH) announced that it would sponsor a landmark study to examine women and cardiovascular disease. Known as the Women's Health Initiative (WHI), the study enrolled more than 161,000 women.

4 Nov 2009

Molecular imaging pinpoints inflammation in the brains of schizophrenics and migraine sufferers

Inflammatory response of brain cells-as indicated by a molecular imaging technique-could tell researchers more about why certain neurologic disorders, such as migraine headaches and psychosis in schizophrenic patients, occur and provide insight into how to best treat them, according to two studies published in the November issue of the Journal of Nuclear Medicine.

31 Oct 2009

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.

28 Oct 2009

Rutgers scientist receives 2009 Gruber International Research Award

For the first time, it now is possible for researchers to peer into those internal processes in a rodent brain. Eva Pastalkova, a post-doctoral researcher at the Center for Molecular and Behavioral Neuroscience at Rutgers University, Newark and her advisor, Professor Gy-rgy Buzsaki, have developed a method for studying internally generated brain activity in rats.

28 Oct 2009

Susceptibility to schizophrenia and autism may have common genetic fingerprints, says researchers

28 Oct 2009

Discovery of molecular pathway in brain may reverse cognitive impact of sleep deprivation

A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation.

27 Oct 2009

Antidepressants are not effective for many people

More than half the people who take antidepressants for depression never get relief.

24 Oct 2009

Research in specific cells and circuitry affected by addiction may help guard against relapse

New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.

22 Oct 2009

Federal grant for ecstasy research

A so-called "club drug" - typically not used all that often by those who take it - can still have the potential to cause a lot of damage among some users, say University of Cincinnati researchers. Trials are underway to trace the effects of ecstasy and to see who's most at risk. The study is supported by $471,000 in federal stimulus funds awarded by the National Institutes of Health and spread out over two years.

19 Oct 2009

Exercise prevents memory decline post brain radiation treatments

Exercise is a key factor in improving both memory and mood after whole-brain radiation treatments in rodents, according to data presented by Duke University scientists at the Society for Neuroscience meeting.

19 Oct 2009

Brain's mapping system uncovered

Through the power of Google Earth, you can travel the globe from the comfort of your computer screen, peering down on everything from above. But once you change your perspective - if you go into one of the buildings that you've looked down on - you have to upload a new map.

7 Oct 2009

Hippocampus News and Research

Further Reading

C3a peptide regulates the generation of new nerve cells in the brain: Study

Foods rich in antioxidant substances could delay the onset of Alzheimer's disease

Brain uses a mechanism to filter out distracting thoughts to focus on single information

Possible new approach to slow the progression of cognitive decline in Down's syndrome

New neuroimaging techniques yield new insights on Alzheimer's disease

Scientists develop new technique to measure brain volume loss for monitoring of Alzheimer's disease

Mithridion reports progress with its potential oral small-molecule drugs for AD and schizophrenia

Weizmann Institute scientists reveal how some aromas are bound up in our memories

Advanced equipment targets radiation to specific areas in the brain

Study: Estrogen replacement may help protect brain damage

Molecular imaging pinpoints inflammation in the brains of schizophrenics and migraine sufferers

Scientists test rapamycin's effectiveness at rescuing impaired nerve cells

Rutgers scientist receives 2009 Gruber International Research Award

Susceptibility to schizophrenia and autism may have common genetic fingerprints, says researchers

Discovery of molecular pathway in brain may reverse cognitive impact of sleep deprivation

Antidepressants are not effective for many people

Research in specific cells and circuitry affected by addiction may help guard against relapse

Federal grant for ecstasy research

Exercise prevents memory decline post brain radiation treatments

Brain's mapping system uncovered

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News